Application Detail
Description of Medical Service
Next generation sequencing panel testing involves nucleic acid extraction from a tissue biopsy sample, which then undergoes target enrichment treatment. Genomic variants are then curated by scientists/pathologists and a clinical report generated.Description of Medical Condition
Non-small cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small cell lung cancer. The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma.Most NSCLC patients have symptoms at the time of diagnosis. Depending on the stage of disease and the type of lung cancer, treatment options may include surgery, radiotherapy, chemotherapy, immunotherapy, or molecularly targeted therapy.Reason for Application
New MBS itemMedical Service Type
Investigative technologyPrevious Application Number/s
Not ApplicableAssociated Documentation
Application Form
Application Form (PDF 678 KB)Application Form (Word 328 KB)
Consultation Survey
Consultation Survey (PDF 316 KB)Consultation Survey (Word 72 KB)
PASC Consultation
Expedited - Bypassing PASC
MSAC Consultation
MSAC consultation input closed Friday, 7 October 2022.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO Confirmation
-Assessment Report
Assessment report (PDF 4071 KB)Assessment report (Word 4168 KB)
Public Summary Document
Public Summary Document (PDF 884 KB)Public Summary Document (Word 420 KB)